Tag Archives: NHL

[NEWS]Minax Global Brand Exchange and New Horizon Longevity Form Strategic Partnership to Build China-US Health Mall

Hong Kong, April 16, 2025 — Against the backdrop of accelerating digital transformation in the global traditional Chinese medicine (TCM) industry, Minax Global Brand Exchange (“Minax”) and New Horizon Longevity Technology Co., Ltd. (“New Horizon Longevity”), a leading enterprise in the modernization of TCM, have officially signed a strategic cooperation agreement. Together, they will build the “China-US Health Mall” to drive the globalization and digital upgrade of the TCM industry. This collaboration marks a deep synergy in the RWA (Real World Asset) space, further reinforcing the innovative presence of TCM in international capital markets.

Joint Development of the China-US Health Mall

Leveraging Minax’s global trading ecosystem and New Horizon Longevity’s R&D expertise, the two parties will create a comprehensive trading platform covering TCM products, health services, and digital assets, facilitating global market access and supporting the international expansion of TCM brands.

Deepening RWA Applications

Core product pipelines such as New Horizon Longevity’s Herbal Vision Eye Care Solution 2.0 will be digitized using blockchain technology to ensure transparency in medicinal material traceability, patented technologies, and brand value—offering global investors new opportunities to participate in the TCM industry.

Dual-Engine Growth: Capital and Industry

Minax will provide marketplace brands with digital asset issuance, cross-border circulation, and financing services, including private placement and crowdfunding tools, accelerating the integration of the TCM industry chain.

Minax and New Horizon Longevity at the signing ceremony

About New Horizon Longevity
New Horizon Longevity leads in eye health research and clinical innovation, laying out a full-chain technology roadmap in diagnosis and treatment.

Its product portfolio includes Herbal Vision Eye Care Solution, Macular Eye Care Solution, and Eye Moisturizing Spray. The Herbal Vision Eye Care Solution is the second single-compound TCM product developed with modern medical technology, following artemisinin. The Macular Eye Care Solution helps alleviate visual impairments caused by macular degeneration, while the Eye Moisturizing Spray can prevent eye diseases and relieve eye strain.

The drug pipeline is globally innovative. The breakthrough R&D pipeline for the Herbal Vision Eye Care Solution 2.0 targets diabetic retinopathy, presbyopia, age-related macular degeneration, cataracts, and glaucoma. The company is also working with the Hong Kong government and Professor Zhou of The Hong Kong Polytechnic University to develop eye drops and oral supplements for diabetic retinopathy and presbyopia. In addition, it is collaborating with Dean Feng of the School of Chinese Medicine at The University of Hong Kong to develop pipelines for diabetic retinopathy and macular degeneration treatments.

Conclusion:
MINAX Global Brand Exchange is jointly established by the MINAX GROUP and KLICKL, the first fully licensed digital asset institution in the MENA region. It is licensed and compliant for digital asset issuance in the UAE.

MINAX partners with professional investment banks, funds, law firms, and auditing firms to create a healthy ecosystem for brands entering the Web3 space. It also enables SMEs and individuals to build and grow their own brands through private placements, crowdfunding, and IBOs. Thanks to the globalization of Web3, brand assets can be traded 24/7 on exchanges worldwide, allowing investors from all corners of the globe to participate in brand investment more easily than ever before.

 

【Risk Warning】This article’s content is for informational purposes only and does not constitute any investment advice. Brand asset trading and investment involve high risks and volatility. Users are advised to fully understand the associated risks and make cautious decisions before investing. MINAX is not responsible for any investment losses resulting from reliance on this content. Please invest rationally based on your risk tolerance.

[NEWS]New Horizon Longevity Successfully Lists as a Brand in Dubai, with Technological Innovation Driving the Internationalization of the Traditional Chinese Medicine Industry

On March 5, 2025, New Horizon Longevity successfully launched trading on the MINAX Global Brand Exchange and held a grand listing ceremony in Dubai, becoming the world’s first brand to promote the industrialization of traditional Chinese medicine through the RWA model. This initiative not only marks an important milestone for traditional Chinese medicine’s entry into the international capital market but also provides new ideas for the globalization and digitalization development of traditional Chinese medicine.

 

Top-notch Platform Empowers the Reconstruction of Brand Value

It is reported that New Horizon Longevity chose to list in Dubai this time, relying on the compliance system of the Minax Global Brand Exchange and taking advantage of the financial innovation environment in the United Arab Emirates to achieve the global circulation of brand assets.
“New Horizon Longevity’s choice of MINAX is a landmark layout for its brand digitization strategy,” said Wang Ping, CEO of New Horizon Longevity, at the ceremony. “By transforming intellectual property rights in the biotechnology field into tradable digital assets, we can not only reach a wider range of global investors but also convey the technical foundation and market potential of Chinese health brands to the world in a transparent and trustworthy manner.”

 

Executive Chairman of the China-US Health Industry Investment and M&A Alliance
Founder and Chairman of New Horizon Longevity Brand – Wang Ping

 

Coexistence of Policy Promotion and Market Opportunities

In recent years, the Chinese government has vigorously promoted the modernization and internationalization of traditional Chinese medicine. In 2022, the total number of consultations in traditional Chinese medicine health institutions across the country reached 1.23 billion, accounting for 14.6% of the total number of consultations nationwide. In 2023, the market scale of the traditional Chinese medicine industry was close to 800 billion yuan, with a growth rate ranking among the top in the pharmaceutical industry. Against this backdrop, the RWA listing of New Horizon Longevity will help enhance the influence of traditional Chinese medicine in the international market.

 

RWA Empowers the Traditional Chinese Medicine Industry Chain and Builds a Global Ecology

The introduction of RWA technology has enabled the traditional Chinese medicine industry to achieve the digitalization and financialization of assets. In the future, New Horizon Longevity will ensure the transparency of core assets such as brand value, traceability of medicinal materials, and patented technologies through blockchain technology, improve market trust, and provide global investors with a new way to participate in the traditional Chinese medicine industry.


Mr. Deng Di, the initiator of MINAX and the first advocate of brand RWA, pointed out that the brand RWA model of New Horizon Longevity is expected to become a digital benchmark in the traditional Chinese medicine industry and promote the capitalization process of the traditional Chinese medicine industry cluster in the international market. At the same time, due to Dubai’s unique geographical advantages and the environment of the integration of multiple cultures, it may become a trading hub for traditional Chinese medicine brand RWA in the future, helping traditional Chinese medicine take root globally.

 

Chairman of Taiyi Group, Director of the Digital Economy Special Committee of the All-China Federation of Mergers and Acquisitions Association
Initiator of MINAX Global Brand Exchange – Deng Di

 

With the accelerated digitalization and intelligence of the traditional Chinese medicine industry, the successful listing of the Novohope Longevity brand will further promote the globalization of the traditional Chinese medicine industry and provide more possibilities for Chinese traditional Chinese medicine to go global.

 

Conclusion:

The MINAX Global Brand Exchange was jointly initiated and established by the MINAX GROUP Global Brand Trading Group and KLICKL, the first full-licensed digital asset institution in MENA (Middle East and North Africa). It has the compliance ability and license support for digital asset issuance in the United Arab Emirates.


MINAX will work together with professional investment banking institutions, investment funds, law firms, and audit firms to create a good ecological environment for brands to enter the Web3 field. MINAX will also provide convenience for small and medium-sized enterprises and even individuals to create and develop their own brands. Through various forms such as brand private placement, brand crowdfunding, and IBO, it will help brands obtain the first financing, the first group of fans, and the first batch of orders. At the same time, due to the global characteristics of Web3, brand assets can be traded 24 hours a day, 7 days a week on various global exchanges, and brand asset investors can come from all corners of the world. Investing in brands has never been so convenient.

As the world’s first brand asset exchange, MINAX has been committed to promoting the RWA process of brands and has made breakthrough progress in multiple markets such as Hong Kong, Macau, and Dubai. MINAX’s brand digital asset solution is becoming an important bridge connecting traditional brands and the Web3 world.


As the first eye health technology enterprise to list on the MINAX Global Brand Exchange, Novohope Longevity has successfully achieved the strategic upgrade of brand digitization through strategic cooperation with MINAX, accelerated its market expansion through its global platform, and further consolidated its international influence in the field of eye health technology.


Novohope Longevity has made remarkable achievements in the field of eye health. With its deep accumulation in scientific research and clinical practice, it has occupied a high ground in the industry and carried out technological innovation around the entire diagnosis and treatment chain, committed to bringing comprehensive and efficient solutions to eye disease patients.

The drug pipeline of Novohope Longevity has significant global innovation. The pipeline of the Herb-based Mingmu Presbyopia Eye Protection Solution 2.0 in its breakthrough drug R&D pipeline is expected to benefit patients with diabetic retinopathy, presbyopia, age-related macular degeneration, cataract, and glaucoma. In addition, the company actively conducts external cooperation. It has joined hands with Professor Zhou from the Hong Kong Polytechnic University and the Hong Kong government to develop eye drops and oral supplements for the treatment of diabetic retinopathy and presbyopia. It has also collaborated with Dean Feng of the School of Chinese Medicine at the University of Hong Kong and the Hong Kong government to advance the research and development of the drug pipeline for diabetic retinopathy and the pipeline for macular degeneration.

With its scientific research strength, rich products, and innovative drug R&D pipeline in the field of eye health, Novohope Longevity is gradually becoming a leading enterprise in the eye health industry and will continue to bring more hope to eye disease patients around the world in the future.

【Risk Warning】This article’s content is for informational purposes only and does not constitute any investment advice. Brand asset trading and investment involve high risks and volatility. Users are advised to fully understand the associated risks and make cautious decisions before investing. MINAX is not responsible for any investment losses resulting from reliance on this content. Please invest rationally based on your risk tolerance.

[Notice]New Horizon Longevity Brand Asset (NHL) Successfully Listed for Trading

Dear Users,

We are pleased to announce that New Horizon Longevity Brand Asset (Code: NHL) has been successfully listed for trading as of 20:00, Marth 5, 2025 (UTC+8). We warmly invite all users to participate in trading!

This listing brings together international research resources to advance global ophthalmic diagnostic and treatment technologies to new heights.

1. Overview of Listing Information

  • Asset Name: New Horizon Longevity Brand Asset
  • Asset Code: NHL
  • Total Issuance: 10,000,000,000 units
  • Initial Circulation Volume: 100,000,000 units
  • Reference Listing Price: 0.001 USD
  • Trading Pair: NHL/USDT
  • Trading Model: 24/7 real-time trading, no price fluctuation limit
  • Trading Entry: Click to Trade
  • Deposit & Withdrawal: Deposit and withdrawal functions are temporarily unavailable. The specific opening time will be announced separately.
  • Related Links: Listing Announcement | Brand Introduction

2. Security Reminders

Risk Warning:

Market prices are influenced by various factors, including market demand, brand promotion, and macroeconomic conditions, leading to potential price volatility. Investors should fully understand the risks, assess their individual risk tolerance, and bear the associated market risks. MINAX provides support for asset trading only and does not assume responsibility for investment outcomes.

Account Security:

Account security is critical. Please complete identity verification, enable multi-factor authentication, and ensure the proper safeguarding of your account information.

3. Important Notes

The content of this announcement is for reference only. All information is subject to the actual operations of the platform. For inquiries, please contact us through official channels at: support@minax.io.

Thank you for your support! MINAX will continue to drive the development of brand asset digitization, aiming to build a premium brand asset trading service ecosystem for users worldwide.

MINAX Platform Features Explained: A Win-Win Model for Brand Financing and Investor Returns >>

MINAX Operations Team
March 5, 2025

Telegram Community (Btok Link) / Social Platform X  /  Contact Us  / About Us

【Risk Reminder】The market is subject to risks; investments require caution. The prices of brand assets may experience significant fluctuations due to market conditions, and investors may incur partial or total losses. Please make prudent decisions based on your own financial situation and investment goals. MINAX, as a trading platform, does not bear responsibility for the results of users’ investments.
【Special Note】MINAX reserves the right to modify, change, or cancel this announcement at its sole discretion at any time without prior notice. In the event of any discrepancies between the English and Traditional Chinese versions of this announcement, the Traditional Chinese version shall prevail. The content of this announcement may be updated as needed; please refer to the latest updates.

[Listing] MINAX Global Premiere: The brand influence of New Horizon Longevity（NHL） is about to be listed

Dear Users,

MINAX Brand Asset Exchange is pleased to announce that New Horizon Longevity (Code:NHL) will be listed for trading on 20:00, March  5, 2025 (UTC+8).

A New TCM Benchmark After Artemisinin. New Horizon Longevity shines brightly on the stage!

Risk Warning: Under the brand influence listing model, the brand party evaluates market popularity through brand transactions and has not yet finalized the scope of assets to be included as brand assets. The brand party does not commit to buybacks or token burns. Investors should exercise caution and bear the risks independently. If the model transitions to a brand asset listing in the future, the brand party will further clarify issuance commitments based on the brand influence listing without conducting a separate issuance.

I. Asset Information

  • Asset Name: New Horizon Longevity Brand Asset
  • Asset Code: NHL
  • Total Issuance: 10,000,000,000 units
  • Initial Circulation Volume: 100,000,000 units
  • Reference Listing Price: 0.001 USD
  • Initial Valuation: 10,000,000 USD
  • Issuance Model: Brand Influence Listing
    Initial Circulation Allocation:
    Community Promotion: 50,000,000 units
    Consumer Rebates: 50,000,000 units

II. Trading Details

  • Listing Time: 2025-03-05 20:00 (UTC+8)
  • Supported Trading Pair: NHL/USDT
  • Trading Mode: 24/7 real-time trading with no price limits
  • Deposit and Withdrawal: Currently unavailable; updates to follow as applicable

III. Brand Background and Highlights

New Horizon Longevity Technology Co., Limited occupies a high ground in eye health research and clinical practice, laying out technological innovation in the entire diagnosis and treatment chain. The product includes Herbal Brightening and Aging Eye Care Liquid, Macular Eye Care Liquid, Eye Moisturizing Spray, etc. Laohua Eye Protection Liquid, a traditional Chinese medicine product under the name of Materia Medica, is the second monomeric product under modern medical technology after artemisinin; Macular eye care solution can alleviate visual impairment caused by macular degeneration; Moisturizing eye spray can prevent eye diseases and relieve visual fatigue. Click to learn more >>

IV. Important Notes

  • Risk Notice: The market involves risks, and investments require caution. Brand asset prices may fluctuate significantly due to market demand, brand promotion, macroeconomic factors, etc. Please understand the risks before investing and make informed decisions. MINAX only provides trading support and is not responsible for investment outcomes.
  • Account Security: Please ensure account information security and complete identity verification to participate in trading smoothly.

Additional Information:

  • The information in this announcement is for reference only and is subject to actual conditions.
  • MINAX reserves the final interpretation right of this announcement.
  • For any questions, please contact official customer support: support@minax.io.

Thank you for your support. MINAX is dedicated to driving innovation in asset branding and creating a win-win trading platform for brands and investors worldwide.
MINAX Platform Guide: New Model for Brand Financing & Investor Gains >>

MINAX Operations Team
March 4, 2025

Telegram Community (Btok Link) / Social Platform X  /  Contact Us  / About Us  /  Download APP

【Risk Reminder】The market is subject to risks; investments require caution. The prices of brand assets may experience significant fluctuations due to market conditions, and investors may incur partial or total losses. Please make prudent decisions based on your own financial situation and investment goals. MINAX, as a trading platform, does not bear responsibility for the results of users’ investments.
【Special Note】MINAX reserves the right to modify, change, or cancel this announcement at its sole discretion at any time without prior notice. In the event of any discrepancies between the English and Traditional Chinese versions of this announcement, the Traditional Chinese version shall prevail. The content of this announcement may be updated as needed; please refer to the latest updates.

[Announcement] Focused on Eye Health Technology Innovation—New Horizon Longevity Has Entered the Pre-Listing Stage

Dear Users,

MINAX Brand Exchange is preparing to list a new brand asset—New Horizon Longevity, which has now entered the pre-listing stage.

Brand Introduction

New Horizon Longevity Technology Co., Limited occupies a high ground in eye health research and clinical practice, laying out technological innovation in the entire diagnosis and treatment chain.
The product includes Herbal Brightening and Aging Eye Care Liquid, Macular Eye Care Liquid, Eye Moisturizing Spray, etc. Laohua Eye Protection Liquid, a traditional Chinese medicine product under the name of Materia Medica, is the second monomeric product under modern medical technology after artemisinin; Macular eye care solution can alleviate visual impairment caused by macular degeneration; Moisturizing eye spray can prevent eye diseases and relieve visual fatigue.

Stay tuned for further updates and details!

Thank you for your support! MINAX remains committed to providing a premium brand asset trading experience for global users.

MINAX Operations Team
February 28, 2025

Telegram Community (Btok Link) / Social Platform X  /  Contact Us  / About Us

【Risk Reminder】The market is subject to risks; investments require caution. The prices of brand assets may experience significant fluctuations due to market conditions, and investors may incur partial or total losses. Please make prudent decisions based on your own financial situation and investment goals. MINAX, as a trading platform, does not bear responsibility for the results of users’ investments.
【Special Note】MINAX reserves the right to modify, change, or cancel this announcement at its sole discretion at any time without prior notice. In the event of any discrepancies between the English and Traditional Chinese versions of this announcement, the Traditional Chinese version shall prevail. The content of this announcement may be updated as needed; please refer to the latest updates.

[Showcase] New Horizon Longevity Technology Co Brand Application Display

Dear Users,

According to the regulations of the MINAX Brand Asset Exchange, the following brand has submitted an application for listing. We are now showcasing its basic information, inviting public attention, and welcoming suggestions or feedback from all sectors.

1. Brand Basic Information

  • Brand Name: New Horizon Longevity Technology Co
  • Brand Introduction:New Horizon Longevity Technology Co., Limited occupies a high ground in eye health research and clinical practice, laying out technological innovation in the entire diagnosis and treatment chain.The product includes Herbal Brightening and Aging Eye Care Liquid, Macular Eye Care Liquid, Eye Moisturizing Spray, etc. Laohua Eye Protection Liquid, a traditional Chinese medicine product under the name of Materia Medica, is the second monomeric product under modern medical technology after artemisinin; Macular eye care solution can alleviate visual impairment caused by macular degeneration; Moisturizing eye spray can prevent eye diseases and relieve visual fatigue.

    The drug pipeline has global innovation. The breakthrough drug R&D pipeline includes the herbal Mingmu Laohua Eye Care Liquid 2.0 pipeline, which will benefit patients with diabetes retinopathy or presbyopia, age-related macular degeneration, cataract and glaucoma; The company cooperates with the Hong Kong government and Professor Zhou of the Hong Kong Polytechnic University to develop eye drops and oral supplements to treat diabetes retinopathy and presbyopia; Cooperate with the Hong Kong government and Dean Feng of the School of Traditional Chinese Medicine of the University of Hong Kong to develop drug pipelines for diabetes retinopathy and macular diseases.

    Introduction to longevity drugs: NAD+products synthesized from traditional Chinese medicine are undergoing clinical research with the School of Chinese Medicine at the University of Hong Kong.

  1. Information Transparency:
    Providing basic brand information for users to understand and ensuring operational transparency on the platform.
  2. Public Oversight:
    Welcoming user feedback to enhance platform services and brand management standards.

3. Feedback Method

4. Special Disclaimer

  1. This display is solely for the purpose of information disclosure. The information is for reference only and does not constitute a formal commitment to the brand’s listing.
  2. The formal inclusion in the public announcement phase and subsequent processes will be determined based on the brand’s qualifications, market evaluation, and compliance review results.

Thank you for your attention and support! MINAX Brand Asset Exchange is committed to fostering a transparent trading environment and providing efficient and innovative brand asset services to our users.

Sincerely,

MINAX Operations Team
February 26, 2025

Telegram Community (Btok Link) / Social Platform X  /  Contact Us  / About Us

【Risk Reminder】The market is subject to risks; investments require caution. The prices of brand assets may experience significant fluctuations due to market conditions, and investors may incur partial or total losses. Please make prudent decisions based on your own financial situation and investment goals. MINAX, as a trading platform, does not bear responsibility for the results of users’ investments.
【Special Note】MINAX reserves the right to modify, change, or cancel this announcement at its sole discretion at any time without prior notice. In the event of any discrepancies between the English and Traditional Chinese versions of this announcement, the Traditional Chinese version shall prevail. The content of this announcement may be updated as needed; please refer to the latest updates.